Ibahan, Floramil G.
HRN: 23-69-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2023
CLINDAMYCIN 300MG (CAP)
10/01/2023
10/07/2023
PO
300mg
TID
S/p CS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes